selegiline has been researched along with Age-Related Memory Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, R; Amini-Khoei, H; Bagheri, N; Mobini, GR; Mokhtari, T; Sabzevary-Ghahfarokhi, M; Saghaei, E | 1 |
| Bagriyanik, HA; Ergur, BU; Kiray, M; Pekcetin, C; Uysal, N | 1 |
| Aráujo, DT; Cunha, GM; Maia, FD; Pitombeira, BS; Viana, GS | 1 |
| Bromberg, E; Caldana, F; de Lima, MN; Laranja, DC; Roesler, R; Schröder, N | 1 |
| Kusumoto, H; Minami, A; Shimazu, S; Takahata, K; Yoneda, F | 1 |
| Bromberg, E; Caldana, F; Dal-Pizzol, F; de Lima, MN; Garcia, VA; Grazziotin, MM; Laranja, DC; Schröder, N | 1 |
| Hafner, U; Müller, WE; Pohl, O; Stoll, S | 1 |
| Filip, V; Kolibás, E | 1 |
| Baillet, C; Callizot, N; Guénet, JL; Poindron, P; Warter, JM | 1 |
1 review(s) available for selegiline and Age-Related Memory Disorders
| Article | Year |
|---|---|
Age-related memory decline and longevity under treatment with selegiline.
Topics: Aging; Animals; Avoidance Learning; Cricetinae; Female; Longevity; Maze Learning; Memory Disorders; Mesocricetus; Mice; Mice, Inbred Strains; Selegiline | 1994 |
1 trial(s) available for selegiline and Age-Related Memory Disorders
| Article | Year |
|---|---|
Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Memory Disorders; Middle Aged; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Neuropsychological Tests; Prospective Studies; Selegiline | 1999 |
7 other study(ies) available for selegiline and Age-Related Memory Disorders
| Article | Year |
|---|---|
Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat.
Topics: Animals; Brain Ischemia; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Selegiline; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Protective effects of deprenyl in transient cerebral ischemia in rats.
Topics: Animals; Escape Reaction; Hippocampus; Ischemic Attack, Transient; Male; Maze Learning; Memory Disorders; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Selegiline; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
l-Deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats.
Topics: Animals; Antioxidants; Avoidance Learning; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lipid Peroxidation; Maze Learning; Memory Disorders; Motor Activity; Neuroprotective Agents; Nitrites; Rats; Rats, Wistar; Selegiline; Thiobarbituric Acid Reactive Substances | 2004 |
Reversal of age-related deficits in object recognition memory in rats with l-deprenyl.
Topics: Aging; Animals; Antiparkinson Agents; Behavior, Animal; Injections; Male; Memory; Memory Disorders; Memory, Short-Term; Rats; Rats, Wistar; Recognition, Psychology; Selegiline | 2005 |
Effects of selegiline alone or with donepezil on memory impairment in rats.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Aziridines; Behavior, Animal; Choline; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Synergism; Escape Reaction; Fenclonine; Indans; Male; Maze Learning; Memory Disorders; Piperidines; Rats; Rats, Inbred F344; Reaction Time; Scopolamine; Selegiline; Time Factors | 2005 |
Selegiline protects against recognition memory impairment induced by neonatal iron treatment.
Topics: Animals; Animals, Newborn; Iron; Male; Memory Disorders; Neuroprotective Agents; Rats; Rats, Wistar; Recognition, Psychology; Selegiline | 2005 |
The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Electromyography; Female; Genes, Recessive; Immunohistochemistry; Indoles; Levodopa; Male; Memory Disorders; Mice; Mice, Inbred C3H; Mice, Neurologic Mutants; Motor Activity; Neurons; Parkinson Disease, Secondary; Postural Balance; Selegiline; Tyrosine 3-Monooxygenase | 2001 |